CLINICAL AUDIT ON RECORDING DOOR-TO-BALLOON TIME IN A TERTIARY CARE HOSPITAL FOR STEMI PATIENTS
Main Article Content
Keywords
ST-Elevation Myocardial Infarction , cardiovascular morbidity , angioplasty , catheterization
Abstract
ST-Elevation Myocardial Infarction (STEMI) is one of the most critical forms of acute coronary syndrome (ACS) and occurs due to complete thrombotic occlusion of a coronary artery, leading to irreversible myocardial necrosis if not treated promptly.
References
1. Ibanez B, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2018;39(2):119–177.
2. World Health Organization. Cardiovascular diseases (CVDs). WHO Fact Sheets. 2021.
3. Keeley EC, Boura JA, Grines CL. Primary angioplasty vs thrombolytic therapy for acute MI: a quantitative review. Lancet. 2003;361(9351):13–20.
4. Widimsky P, et al. Long-distance transport for primary angioplasty vs thrombolysis. Eur Heart J. 2003;24(1):94–104.
5. O’Gara PT, et al. ACCF/AHA STEMI Guidelines. Circulation. 2013;127:e362–e425.
6. De Luca G, et al. Time delay to treatment and mortality in primary angioplasty for AMI: Every minute counts. Circulation. 2004;109(10):1223–1225.
7. Pinto DS, et al. Hospital delays in reperfusion for STEMI: Implications for PCI vs thrombolysis. Circulation. 2006;114:2019–2025.
8. Rathore SS, et al. Association of D2B time and mortality in STEMI. BMJ. 2009;338:b1807.
9. Gibson CM, et al. Trends in door-to-balloon times and STEMI care. Am Heart J. 2008;156(6):1035–1044.
10. Ahmed U, Khan A. Audit of Myocardial Infarction Cases in Quetta: Outcomes and Delays. Balochistan Medical Journal. 2024;10(1):23–28.
11. Baloch A, Sadiq S, Khan A, et al. Cardiovascular disease in Balochistan: burden, risk factors, and strategies for prevention. BMC Cardiovasc Disord. 2020;20:15. doi: 10.1186/s12872-020- 01473-4.
12. Iqbal F, Ahmed K, Qureshi M, et al. Prevalence and management of acute myocardial infarction in Balochistan: A study from Quetta. J Pak Med Assoc. 2022;72(5):948-953.
2. World Health Organization. Cardiovascular diseases (CVDs). WHO Fact Sheets. 2021.
3. Keeley EC, Boura JA, Grines CL. Primary angioplasty vs thrombolytic therapy for acute MI: a quantitative review. Lancet. 2003;361(9351):13–20.
4. Widimsky P, et al. Long-distance transport for primary angioplasty vs thrombolysis. Eur Heart J. 2003;24(1):94–104.
5. O’Gara PT, et al. ACCF/AHA STEMI Guidelines. Circulation. 2013;127:e362–e425.
6. De Luca G, et al. Time delay to treatment and mortality in primary angioplasty for AMI: Every minute counts. Circulation. 2004;109(10):1223–1225.
7. Pinto DS, et al. Hospital delays in reperfusion for STEMI: Implications for PCI vs thrombolysis. Circulation. 2006;114:2019–2025.
8. Rathore SS, et al. Association of D2B time and mortality in STEMI. BMJ. 2009;338:b1807.
9. Gibson CM, et al. Trends in door-to-balloon times and STEMI care. Am Heart J. 2008;156(6):1035–1044.
10. Ahmed U, Khan A. Audit of Myocardial Infarction Cases in Quetta: Outcomes and Delays. Balochistan Medical Journal. 2024;10(1):23–28.
11. Baloch A, Sadiq S, Khan A, et al. Cardiovascular disease in Balochistan: burden, risk factors, and strategies for prevention. BMC Cardiovasc Disord. 2020;20:15. doi: 10.1186/s12872-020- 01473-4.
12. Iqbal F, Ahmed K, Qureshi M, et al. Prevalence and management of acute myocardial infarction in Balochistan: A study from Quetta. J Pak Med Assoc. 2022;72(5):948-953.
